Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

How reliable is MRI for predicting extent of residual breast cancer with different primary medical therapies?

Nature Clinical Practice Oncology volume 2, pages 128–129 (2005)Cite this article

boxed-textDenis F et al. (2004) Contrast-enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel-based chemotherapy for breast cancer. Eur J Surg Oncol 30: 1069–1076

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. van der Hage JA et al. (2001) Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19: 4224–4237

    Article  CAS  Google Scholar 

  2. Fisher B et al. (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16: 2672–2685

    Article  CAS  Google Scholar 

  3. Hutcheon AW et al. (2003) Neoadjuvant docetaxel in locally advanced breast cancer. Breast Cancer Res Treat 79 (Suppl 1): S19–S24

    Article  CAS  Google Scholar 

  4. Warren RM et al. (2004) Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br J Cancer 90: 1349–1360

    Article  CAS  Google Scholar 

  5. Guo XL et al. (2003) Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell. World J Gastroenterol 9: 1995–1998

    Article  CAS  Google Scholar 

  6. Martincich L et al. (2004) Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 83: 67–76

    Article  Google Scholar 

  7. Douek M et al. (1998) Can magnetic-resonance imaging help elucidate natural history of breast cancer multicentricity? Lancet 351: 801–802

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Senior Lecturer and Consultant Surgeon at the Royal Free and University College Medical School, London

    Michael Douek

  2. Professor of Cancer Medicine at the Royal Free and University College Medical School, London

    Jeffrey Tobias

Authors
  1. Michael Douek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey Tobias
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeffrey Tobias.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Glossary

NEOADJUVANT CHEMOTHERAPY

Chemotherapy given to patients before surgery

RECIST CRITERIA

Criteria for measuring tumor shrinkage as an indicator of antitumor activity, as evaluated by the Response Evaluation Criteria in Solid Tumors Group (RECIST)

PRIMARY MEDICAL THERAPY

Treatment given to reduce tumor size prior to surgery, which may include chemotherapy or radiotherapy. Synonym for neoadjuvant therapy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Douek, M., Tobias, J. How reliable is MRI for predicting extent of residual breast cancer with different primary medical therapies?. Nat Rev Clin Oncol 2, 128–129 (2005). https://doi.org/10.1038/ncponc0105

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0105

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing